U.S. markets close in 3 hours 25 minutes
  • S&P 500

    3,675.36
    +6.35 (+0.17%)
     
  • Dow 30

    30,061.28
    +177.49 (+0.59%)
     
  • Nasdaq

    12,411.21
    +61.85 (+0.50%)
     
  • Russell 2000

    1,858.67
    +20.65 (+1.12%)
     
  • Crude Oil

    45.63
    +0.35 (+0.77%)
     
  • Gold

    1,838.70
    +8.50 (+0.46%)
     
  • Silver

    24.10
    +0.02 (+0.10%)
     
  • EUR/USD

    1.2152
    +0.0037 (+0.30%)
     
  • 10-Yr Bond

    0.9180
    -0.0300 (-3.16%)
     
  • GBP/USD

    1.3491
    +0.0116 (+0.86%)
     
  • USD/JPY

    103.8280
    -0.5960 (-0.57%)
     
  • BTC-USD

    19,304.63
    +355.73 (+1.88%)
     
  • CMC Crypto 200

    379.70
    +5.29 (+1.41%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Mirati: 3Q Earnings Snapshot

·1 min read

SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Wednesday reported a loss of $87.3 million in its third quarter.

The San Diego-based company said it had a loss of $1.96 per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $2.04 per share.

The biopharmaceutical company posted revenue of $11.4 million in the period.

Mirati shares have climbed 82% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $234.68, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX